VEGFB and ovarian carcinoma: hsa-miR-484, which was upregulated in R2 vs. HC, is associated with chemoresistance in ovarian cancer due to enhanced angiogenesis, resulting from modulation of the tumor vasculature, through regulation of VEGFB and VEGFR2 pathways (51).